Encapsulation and controlled release. (2005)
- Record Type:
- Book
- Title:
- Encapsulation and controlled release. (2005)
- Main Title:
- Encapsulation and controlled release
- Further Information:
- Note: Edited by D.R. Karsa, R.A. Stephenson.
- Other Names:
- Karsa, D. R
Stephenson, R. A - Contents:
- Front Cover; Encapsulation and Controlled Release; Copyright Page; Introduction; Table of Contents; Chapter 1. Industrial Microencapsulation: Polymers for Microcapsule Walls; INTRODUCTION; REASONS FOR MICROENCAPSULATION; PRODUCTION OF MICROCAPSULES; CAPSULE WALL POLYMERS; PRODUCTION FACTORS AFFECTING MICROCAPSULE SIZE; PRODUCTION FACTORS AFFECTING CAPSULE 'QUALITY'; MICROCAPSULE SIZE IN RELATION TO PRODUCTION METHOD; ECONOMIC CONSIDERATIONS; REFERENCES; Chapter 2. Design of Polymeric Drug Delivery Systems for Controlled Release of Antitumour Agents; INTRODUCTION; RESULTS AND DISCUSSION. CONCLUSIONSACKNOWLEDGEMENTS; REFERENCES; Chapter 3. The Use of Gelatin and Alginate for the Immobilization of Bioactive Agents; 1. Introduction; 2. Immobilization of a microorganism and enzymes in gelatin; 3. Immobilization of pesticides in alginate beads; Acknowledgments; 4. References; Chapter 4. Microcapsules from Multiple Emulsions; 1 INTRODUCTION; 2 MULTIPLE EMULSIONS; 3 PREPARATION OF MICROCAPSULES; REFERENCES; Chapter 5. Biodegradable Microspheres for Controlled Drug Delivery; CONTENTS; References; Chapter 6. Nanoparticles -- Colloidal Delivery Systems for Drugs and Vaccines. 1 INTRODUCTION2 PREPARATION OF NANOPARTICLES; 3 BODY DISTRIBUTION OF INTRAVENOUSLY OR PERORALLY ADMINISTERED NANOPARTICLES; 4 APPLICATION OF NANOPARTICLES; REFERENCES; Chapter 7. Liposomes and Polysialic Acids as Drug Delivery Systems; 1 INTRODUCTION; 2 LIPOSOMES; POLYSIALIC ACIDS; REFERENCES; Chapter 8.Front Cover; Encapsulation and Controlled Release; Copyright Page; Introduction; Table of Contents; Chapter 1. Industrial Microencapsulation: Polymers for Microcapsule Walls; INTRODUCTION; REASONS FOR MICROENCAPSULATION; PRODUCTION OF MICROCAPSULES; CAPSULE WALL POLYMERS; PRODUCTION FACTORS AFFECTING MICROCAPSULE SIZE; PRODUCTION FACTORS AFFECTING CAPSULE 'QUALITY'; MICROCAPSULE SIZE IN RELATION TO PRODUCTION METHOD; ECONOMIC CONSIDERATIONS; REFERENCES; Chapter 2. Design of Polymeric Drug Delivery Systems for Controlled Release of Antitumour Agents; INTRODUCTION; RESULTS AND DISCUSSION. CONCLUSIONSACKNOWLEDGEMENTS; REFERENCES; Chapter 3. The Use of Gelatin and Alginate for the Immobilization of Bioactive Agents; 1. Introduction; 2. Immobilization of a microorganism and enzymes in gelatin; 3. Immobilization of pesticides in alginate beads; Acknowledgments; 4. References; Chapter 4. Microcapsules from Multiple Emulsions; 1 INTRODUCTION; 2 MULTIPLE EMULSIONS; 3 PREPARATION OF MICROCAPSULES; REFERENCES; Chapter 5. Biodegradable Microspheres for Controlled Drug Delivery; CONTENTS; References; Chapter 6. Nanoparticles -- Colloidal Delivery Systems for Drugs and Vaccines. 1 INTRODUCTION2 PREPARATION OF NANOPARTICLES; 3 BODY DISTRIBUTION OF INTRAVENOUSLY OR PERORALLY ADMINISTERED NANOPARTICLES; 4 APPLICATION OF NANOPARTICLES; REFERENCES; Chapter 7. Liposomes and Polysialic Acids as Drug Delivery Systems; 1 INTRODUCTION; 2 LIPOSOMES; POLYSIALIC ACIDS; REFERENCES; Chapter 8. Encapsulation in Softgels for Pharmaceutical Advantage; 1. ABSTRACT; 2. INTRODUCTION; 3. TECHNICAL ADVANTAGES; 4. MANUFACTURE OF SOFT GELATIN CAPSULES; 5. HYDROPHILIC FORMULATIONS; 6. ENHANCED SOLUBILITY SYSTEM; 7. IMPROVED DRUG ABSORPTION; References. Chapter 9. Small Packages That Deliver Big Ideas: an Inside Look into Microcapsule Technology1. What is 3M Microencapsulation?; 2. How Microencapsulation is produced; 3. Microencapsulation Product Protection; 4. Applications in Sampling; 5. Current Uses of Capsules in Cosmetics; 6. Future Applications; Chapter 10. On-line Monitoring and Control of the (Co- )Polymer Encapsulation of TiO2 in Aqueous Emulsion Systems; ABSTRACT; 1 INTRODUCTION; REFERENCES; 2 EXPERIMENTAL; 3 STABILITY AND EFFICIENCY OF ENCAPSULATION REACTIONS; REFERENCES; 4 COMPATIBILITY; REFERENCES; 5 CONCLUDING REMARKS. ACKNOWLEDGEMENTChapter 11. Why Infusion and Not Microcapsules or Other Controlled Release Methods?; Introduction; Reasons for Peptide Delivery Research; Difficulties Involved and Formulation Concerns; Development of Biotechnology Drugs; Requirements for a Drug Delivery System; Advantages of the Infusion Technology; Possible Dosage Forms Have Polymers; Chapter 12. Polymeric Formulations of Pest Control Agents; 1. INTRODUCTION; 2. PROCESS REVIEW; 3. ALLIED COLLOIDS LTD PRODUCTS AND PROCESSES FOR MICROENCAPSULATION; 4. THE ACL FORMULATION PROCESS USED; 7. CONCLUSIONS; REFERENCES. … (more)
- Publisher Details:
- Cambridge, England : Woodhead Publishing
- Publication Date:
- 2005
- Copyright Date:
- 2005
- Extent:
- 1 online resource (187 pages), illustrations
- Subjects:
- 615.191
Microencapsulation -- Congresses
Controlled release technology -- Congresses
Controlled release preparations -- Congresses
Controlled release preparations
Controlled release technology
Microencapsulation
Electronic books
Conference papers and proceedings - Languages:
- English
- ISBNs:
- 9781845698218
1845698215 - Related ISBNs:
- 9781855738201
- Notes:
- Note: Includes bibliographical references at the end of each chapters and index.
Note: Online resource; title from PDF title page (ebrary, viewed February 8, 2014). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.38316
- Ingest File:
- 01_015.xml